Lyka Labs Ltd 31 Oct 2026 12:00 AM
Lyka Labs Ltd consolidated sales up 4.47% on year in Q3FY2026,
Lyka Labs Ltd share price declined by 0.22% to Rs 77.0 after the company`s net profit tanked by 38.05% to Rs 1.27 crore, while revenue from operations slightly gained 4.47% to Rs 44.2 crore in Q3FY26 over Q2FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.58 lakh crore, gaining 4.48%. It has improved by 6.57% over last one week and moved up slightly by 1.39% in last one month while the market capitalization of Lyka Labs Ltd has eased by 7.83% and 27.67% in the same period respectively. Profit before tax (PBT) of Lyka Labs Ltd stood at Rs 1.07 crore in Q3 FY26, tumbling by 124.43% year-on-year, and nosediving by 45.13% quarter-on-quarter. EBITDA came in at Rs 3 crore, crashing by 179.89% YoY and plunging by 29.78% sequentially. Total expenses grew marginally by 7.44% to Rs 42.73 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 13.58 crore, soaring by 21.25% YoY, while employee benefits expense was at Rs 12.58 crore, expanding by 9.49% YoY. For the TTM ended FY26, revenue from operations declined slightly by 7.26% to Rs 128.44 crore, while net profit witnessed a sharp fall of 231.65% to Rs 10.44 crore, compared to previous TTM. EBITDA surged by 1640% to Rs 7.16 crore, and PBT tumbled by 205.94% to Rs 11.78 crore compared to previous TTM. The company`s consolidated net cash flow from operating activities stood at Rs 5.24 crore in FY26, as against Rs 1.9 crore in FY25. Lyka Labs Ltd nosedived by 18.52% in last one year, underperforming the benchmark BSE Sensex which has declined by 11.78% during the same period.
Lyka Labs Ltd 14 Oct 2026 12:00 AM
Lyka Labs to review Q2 and H1 financial results at board meeting October 30,
Lyka Labs Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, along with a limited review report from its statutory auditor, and the results will be available on the company’s website at www.lykalabs.com.
Lyka Labs Ltd 08 Oct 2026 12:00 AM
Lyka Labs confirms securities dematerialization acceptance via MUFG Intime India,
Lyka Labs Limited, in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, has received a certificate from MUFG Intime India Private Limited, formerly known as Link Intime India Private Limited, for the quarter ended September 30, 2026, confirming the acceptance or rejection of securities received for dematerialisation and their subsequent listing on stock exchanges.
Lyka Labs Ltd 24 Sep 2026 12:00 AM
Lyka Labs restricts trading for insiders pending Q2 financial results announcement,
Lyka Labs Limited informed the BSE Limited and National Stock Exchange of India Limited that trading in the company`s securities will be closed for Designated Persons and their immediate relatives from Thursday, October 1, 2026, until 48 hours after the announcement of the company’s unaudited financial results for the second quarter ending September 30, 2026, in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.
Lyka Labs Ltd 10 Aug 2026 12:00 AM
Lyka Labs consolidated net profit rises 122.58% in the June 2026 quarter,
Net profit of Lyka Labs rose 122.58% to Rs 2.07 crore in the quarter ended June 2026 as against Rs 0.93 crore during the previous quarter ended June 2025. Sales rose 28.10% to Rs 42.31 crore in the quarter ended June 2026 as against Rs 33.03 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales42.3133.03 28 OPM %10.7511.17 - PBDT3.963.46 14 PBT1.951.35 44 NP2.070.93 123 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now